Skip to main content

Month: August 2021

Vertex Mid-Year Report Shows Sales Tax Rates and Rules Changes Poised for Record Year

Report reveals rapid acceleration of new tax laws as city and district taxes continued to spike in July KING OF PRUSSIA, Pa., Aug. 23, 2021 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX) and its subsidiaries, (“Vertex” or the “Company”), a global provider of tax technology solutions, announced its Mid-Year Rates and Rules Report indicated that new district sales taxes rose rapidly for the first half of this year. Cities are also enacting a higher number of new sales tax rates and changing rates more frequently. These trends have continued through July. “Indirect tax teams need to keep on top of new and shifting rates as the pandemic continues to affect tax revenues,” said Vertex Chief Tax Officer Michael Bernard. “Despite receiving federal aid to the tune of about $350 billion in March of 2021, we saw a flurry of activity from state...

Continue reading

PetVivo Changes Brand Name of Signature Osteoarthritis Product to “SPRYNG”

SPRYNGPetVivo Changes Brand Name of Signature Osteoarthritis Product to “SPRYNG”MINNEAPOLIS, MN, US, Aug. 23, 2021 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce that the Company has changed the brand name of its therapeutic osteoarthritis and lameness product to “SPRYNG”. “We are incredibly excited to introduce to the world the new brand name for our therapeutic product that squarely addresses the debilitating impact of osteoarthritis and lameness in companion animals.” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “The brand name “SPRYNG” clearly illustrates how PetVivo’s product enhances the mobility and overall...

Continue reading

SomaLogic Provides 2021 Financial Guidance Exceeding Initial Merger Combination Projections

NEW YORK and BOULDER, Colo., Aug. 23, 2021 (GLOBE NEWSWIRE) — CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc. (“SomaLogic” or the “Company”), a leader in AI-data driven proteomics technology, today announced that with the approach of the business combination closing, the Company expects projected financial results to be above the previous projections disclosed on March 29, 2021. Full year 2021 revenue is expected to exceed previous full year projections of $66.7 million by 10% or higher. Full year 2021 gross margins are expected to be more than 500 basis points ahead of previously provided full year projections of 51%.  “I am beyond pleased with our performance in the first half of 2021 in which we exceeded our expectations with stronger revenue, better gross margins, faster commercial team ramp, and above-plan clinical...

Continue reading

Avanti Residential Acquires $105 Million Apartment Community in South Florida

341-unit complex in Boynton Beach, FL marks Avanti’s first multifamily investment in the region as the firm expands its apartment holdings nationwideAvanti Residential 500 Ocean341-unit complex in Boynton Beach, FL marks Avanti’s first multifamily investment in the region as the firm expands its apartment holdings nationwideChris Garner, CEO, Avanti ResidentialChris Garner, CEO, Avanti ResidentialDENVER and BOYNTON BEACH, Fla., Aug. 23, 2021 (GLOBE NEWSWIRE) — Avanti Residential announces the acquisition of 500 Ocean, a 341-unit class A apartment community in Boynton Beach, FL, for $105 million ($308,000 per unit). The purchase is part of Avanti’s ongoing nationwide investment strategy to significantly increase its apartment holdings as the sector continues to shine as a favored real estate...

Continue reading

Quipt Adds 15,000 Active Patients With Closing of Strategic Acquisition Within a Metro Hub of Missouri

$5.5 Million in Annualized Revenues, 20% Adjusted EBITDA Margin Post Integration Expected, 1,500 Unique Referring Physicians Added CINCINNATI, Aug. 23, 2021 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that it has recently acquired a business with operations in Missouri, reporting unaudited trailing 12-month annual revenues of approximately $5.5 million, and Adjusted EBITDA (defined below) of $1.1 million expected, post integration. As a reminder all figures stated are in USD. Acquisition Details The acquisition adds three locations, 15,000 active patients, 1,500 unique referring physicians, important insurance contracts and decades of operating experience,...

Continue reading

ISW Holdings Reports Financial Data on 3 Months Ended June 30, Provides Corporate Update

Assets up over 2,500%, derivative liabilities down over 96% as Company fires up mining and hosting operations and adds top-tier partnerships LAS VEGAS, Aug. 23, 2021 (GLOBE NEWSWIRE) — via InvestorWire – ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company,” transitioning to “BlockQuarry,” pending name change), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining, is pleased to announce the filing of the Company’s financial performance data for the three months ended June 30, 2021. “Our primary mining equipment was not installed and switched on until about two weeks before the end of Q2, so the bulk of the impact will show up in Q3 data in terms of topline numbers,” commented Alonzo Pierce, president and chairman of ISW Holdings. “That said, we have significant equipment now...

Continue reading

VivoPower International PLC Reports Preliminary Unaudited Financial Results for the Fiscal Year Ended June 30, 2021

Completed strategic transformation to sustainable energy solution (“SES”)Acquired Tembo e-LV; distribution partner potential commitments for nearly 5,000 electric vehicle conversion kitsRaised $32 million in net proceeds from equity offerings; balance sheet fortifiedAnnual revenues of $40.4 million, impacted by COVID lockdownsUnderlying EBITDA decline to ($1.4) million loss from $3.9 million profit in FY20 LONDON, Aug. 23, 2021 (GLOBE NEWSWIRE) — VivoPower International PLC (NASDAQ: VVPR) (“VivoPower,” the “Company”) today announced its preliminary results for the fiscal year ended June 30, 2021. Highlights for the fiscal year ended June 30, 2021:Annual group revenues of $40.4 million, down 16% year-on-year, primarily due to COVID-19 related lockdowns resulting in project deferrals and operational disruptions, particularly in...

Continue reading

Iceland Seafood International hf: 1H 2021 results and electronic investors meeting

Iceland Seafood will publish its interim consolidated financial statement for 1H 2021 after closing of markets on August 26th 2021. The same day at 4.15pm, the company will host an online meeting for investors and market participants, where management will present and discuss the results. The meeting will be webcasted live in Icelandic. A link to the webcast and investor presentation will be provided before the meeting commence.  Participants to the meeting can send questions in writing prior and during the meeting to the email investors@icelandseafood.com.

Continue reading

Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine

Based on successfully achieving certain milestones primarily related to the execution of a Phase 3 trial and development of large-scale manufacturing processes, Bavarian Nordic will be eligible to receive up to DKK 800 million Agreement aims to strengthen reliability and security of supply of COVID-19 vaccines to meet future revaccination demandsCOPENHAGEN, Denmark, August 23, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company has entered a funding agreement with the Danish Ministry of Health to further advance the development of ABNCoV2, the Company’s COVID-19 vaccine candidate. The agreement is valued at up to DKK 800 million and aims to support the completion of the development towards licensure of ABNCoV2 as a booster vaccine, which could help strengthen the reliability and security of supply of COVID-19 vaccines...

Continue reading

Athira Pharma to Present on ERP P300 as a Direct, Functional, Non-Invasive Biomarker at the Annual Biomarkers for Alzheimer’s Disease Summit

BOTHELL, Wash., Aug. 23, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that Chief Medical Officer, Hans Moebius, will present on the application of clinically established Evoked-Response Potentials (ERPs) by using ERP P300 in Alzheimer’s drug development, and the utility of ERP P300 in Athira’s Phase 1 clinical trials, at the Annual Biomarkers for Alzheimer’s Disease Summit taking place virtually August 24-26, 2021. Presentation Details: Title: Advances in Direct, Functional, Non-Invasive Biomarkers; Athira’s Utilization of ERP P300Presenter: Hans J. Moebius, MD, PhD, Chief Medical Officer, Athira Pharma, Inc.Date: Wednesday, August 25, 2021Time: 12:10 p.m. PT...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.